MedTrace Logo

European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System

NCT01671462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1365

Last updated 2014-02-20

No results posted yet for this study

Summary

The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from SurePath media diluted in HPV diluent (pre-quot and/or residual), PreservCyt media diluted in HPV diluent (pre-quot and/or residual) and a BD cervical brush in BD transport medium to reference histology results from biopsy.

Conditions

  • Uterine Cervical Neoplasms

Interventions

DEVICE

BD HPV assay on Viper LT

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Principal Investigators

  • Irene Hannet, MD · Becton, Dickinson and Company

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Denmark
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01671462 on ClinicalTrials.gov